Home
/
GLOBUS MEDICAL INC
/
Financials
/
Quarterly
GLOBUS MEDICAL INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GLOBUS MEDICAL INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$769.05M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$745.34M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$598.12M
May 8, 2025
Q3
2025
Sep 30, 2024
$625.71M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$629.69M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$606.67M
May 8, 2025
Q3
2024
Sep 30, 2023
$383.64M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$291.62M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$276.69M
May 7, 2024
Q3
2023
Sep 30, 2022
$254.15M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$263.65M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$230.55M
May 4, 2023
Q3
2022
Sep 30, 2021
$229.72M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$251.02M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$227.34M
May 10, 2022
Q3
2021
Sep 30, 2020
$216.10M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$148.92M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$190.58M
May 4, 2021
Q3
2019
Mar 31, 2020
$190.58M
May 7, 2020
Q3
2020
Sep 30, 2019
$196.22M
Oct 28, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$174.41M
May 3, 2018
Q3
2017
Sep 30, 2017
$151.74M
Nov 9, 2017
Q2
2017
Jun 30, 2017
$152.39M
Aug 3, 2017
Q1
2018
Mar 31, 2017
$155.81M
May 3, 2018
Q3
2017
Sep 30, 2016
$135.65M
Nov 9, 2017
Q2
2017
Jun 30, 2016
$137.49M
Aug 3, 2017
Q1
2017
Mar 31, 2016
$139.26M
May 4, 2017
Q3
2016
Sep 30, 2015
$136.99M
Nov 9, 2016
Q2
2016
Jun 30, 2015
$133.57M
Jul 27, 2016
Q1
2016
Mar 31, 2015
$131.60M
May 4, 2016
Q3
2015
Sep 30, 2014
$117.79M
Nov 4, 2015
Q2
2015
Jun 30, 2014
$113.57M
Jul 31, 2015
Q1
2015
Mar 31, 2014
$114.21M
May 5, 2015
Q3
2014
Sep 30, 2013
$107.19M
Oct 31, 2014
Q2
2014
Jun 30, 2013
$107.01M
Aug 6, 2014
Q1
2014
Mar 31, 2013
$105.02M
Apr 30, 2014
Q3
2013
Sep 30, 2012
$94.76M
Oct 31, 2013
Q2
2013
Jun 30, 2012
$95.98M
Aug 2, 2013
Q1
2013
Mar 31, 2012
$94.72M
May 3, 2013
Q3
2012
Sep 30, 2011
$84.27M
Nov 2, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$118.97M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$202.85M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$75.46M
May 8, 2025
Q3
2025
Sep 30, 2024
$51.84M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$31.76M
Aug 7, 2025
Q1
2025
Mar 31, 2024
($7.12M)
May 8, 2025
Q3
2024
Sep 30, 2023
$998.0K
Nov 5, 2024
Q2
2024
Jun 30, 2023
$57.71M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$49.13M
May 7, 2024
Q3
2023
Sep 30, 2022
$47.43M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$54.59M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$38.08M
May 4, 2023
Q3
2022
Sep 30, 2021
$47.21M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$41.55M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$45.33M
May 10, 2022
Q3
2021
Sep 30, 2020
$44.22M
Nov 4, 2021
Q2
2021
Jun 30, 2020
($20.84M)
Aug 4, 2021
Q1
2021
Mar 31, 2020
$25.95M
May 4, 2021
Q3
2019
Mar 31, 2020
$25.95M
May 7, 2020
Q3
2020
Sep 30, 2019
$38.31M
Oct 28, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$137.36M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$76.11M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$97.00M
May 8, 2025
Q3
2025
Sep 30, 2024
$48.10M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$49.62M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$8.00M
May 8, 2025
Q3
2024
Sep 30, 2023
$404.0K
Nov 5, 2024
Q2
2024
Jun 30, 2023
$66.21M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$56.40M
May 7, 2024
Q3
2023
Sep 30, 2022
$59.70M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$67.78M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$46.45M
May 4, 2023
Q3
2022
Sep 30, 2021
$53.33M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$45.88M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$54.55M
May 10, 2022
Q3
2021
Sep 30, 2020
$50.01M
Nov 4, 2021
Q2
2021
Jun 30, 2020
($25.56M)
Aug 4, 2021
Q1
2021
Mar 31, 2020
$28.45M
May 4, 2021
Q3
2019
Mar 31, 2020
$28.45M
May 7, 2020
Q3
2020
Sep 30, 2019
$42.06M
Oct 28, 2020